Stocks and Investing Stocks and Investing
Wed, September 6, 2023

Derek Archila Maintained (ASND) at Buy with Decreased Target to $134 on, Sep 6th, 2023


Published on 2024-10-28 06:17:16 - WOPRAI, Derek Archila
  Print publication without navigation


Derek Archila of Wells Fargo, Maintained "Ascendis Pharma A/S" (ASND) at Buy with Decreased Target from $139 to $134 on, Sep 6th, 2023.

Derek has made no other calls on ASND in the last 4 months.



There are 2 other peers that have a rating on ASND. Out of the 2 peers that are also analyzing ASND, 1 agrees with Derek's Rating of Hold. Following is the relevant analyst calls for the last 4 months


  • Tiago Fauth of "Credit Suisse" Initiated at Hold and Held Target at $89 on, Wednesday, June 14th, 2023


This is the rating of the analyst that currently disagrees with Derek


  • Li Watsek of "Cantor Fitzgerald" Reiterated at Buy and Held Target at $152 on, Thursday, June 1st, 2023
Contributing Sources